高级检索
当前位置: 首页 > 详情页

Econazole nitrate reversed the resistance of breast cancer cells to Adriamycin through inhibiting the PI3K/AKT signaling pathway

| 导出 |

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Kunming Med Univ, Yunnan Tumor Hosp, Affiliated Hosp 3, Dept Med Oncol 2, Kunming, Yunnan, Peoples R China [2]Kunming Med Univ, Yunnan Tumor Hosp, Affiliated Hosp 3, Dept Thorac Surg 2, Kunming, Yunnan, Peoples R China [3]Kunming Med Univ, Yunnan Tumor Hosp, Affiliated Hosp 3, Dept Breast Surg, Kunming, Yunnan, Peoples R China [4]Navy Med Univ, Dept Urol, Changhai Hosp, Second Mil Med Univ, Shanghai, Peoples R China [5]Kunming Childrens Hosp, Dept Otolaryngol Head & Neck Surg, Kunming, Yunnan, Peoples R China [6]SDIVF R&D Ctr, Sha Tin, Hong Kong Sci Pk, Hong Kong, Peoples R China [7]Chinese Univ Hong Kong, Sch Biomed Sci, CUHK SDU Joint Lab Reprod Genet, Sha Tin, Hong Kong, Peoples R China [8]Chinese Acad Sci, Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, 32 Jiaochang East Rd, Kunming 650223, Yunnan, Peoples R China [9]Kunmming Med Univ, Sch Publ Hlth, Kunming, Yunnan, Peoples R China [10]Kunming Med Univ, Dept Urol, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China [11]Zhengzhou Univ, Acad Med Sci, Inst Med & Pharmaceut Sci, Sci Ave 100, Zhengzhou 450001, Henan, Peoples R China
出处:
ISSN:

关键词: Econazole PI3K AKT Adriamycin drug resistance breast cancer

摘要:
Activation of the phosphoinositide 3 kinase (PI3K)/AKT pathway is frequently implicated in resistance to anti cancer therapies. PI3K inhibitors can restore sensitivity to standard breast cancer therapies, including endocrine therapy, HER2-targeted agents, and chemotherapy. Our previous research showed that econazole, a novel PI3Ka Inhibitor, inhibits the PI3K/AKT pathway and induces apoptosis in lung cancer cells. In this study, econazole showed significant cytotoxic activity against Adriamycin-resistant breast cancer cells in vitro and in vivo. Additionally, econazole significantly sensitized MDA-MB-231 and MCF-7 cells to Adriamycin via inhibiting the PI3K/AKT pathway. Overexpression of constitutively active AKT1 abolished the function of econazole. The combination of econazole and Adriamycin exerted synergistic inhibitory effects in breast cancer cells in vitro and in vivo. Taken together, the PI3K inhibitor econazole could effectively overcome Adriamycin resistance and showed synergistic effects with chemotherapy on breast cancer.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2021]版:
大类 | 2 区 医学
小类 | 3 区 肿瘤学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 肿瘤学
JCR分区:
出版当年[2020]版:
Q2 ONCOLOGY
最新[2023]版:
Q2 ONCOLOGY

影响因子: 最新[2023版] 最新五年平均 出版当年[2020版] 出版当年五年平均 出版前一年[2019版] 出版后一年[2021版]

第一作者:
第一作者机构: [1]Kunming Med Univ, Yunnan Tumor Hosp, Affiliated Hosp 3, Dept Med Oncol 2, Kunming, Yunnan, Peoples R China
通讯作者:
通讯机构: [8]Chinese Acad Sci, Chinese Acad Sci & Yunnan Prov, Kunming Inst Zool, Key Lab Anim Models & Human Dis Mech, 32 Jiaochang East Rd, Kunming 650223, Yunnan, Peoples R China [11]Zhengzhou Univ, Acad Med Sci, Inst Med & Pharmaceut Sci, Sci Ave 100, Zhengzhou 450001, Henan, Peoples R China
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:53661 今日访问量:0 总访问量:1665 更新日期:2024-11-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)